Claire Bombardier

Claire Bombardier's AcademicInfluence.com Rankings

Claire Bombardier

Philosophy

#4720

Historical Rank

Logic

#1350

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Claire Bombardier's Degrees

Doctorate Medicine Stanford University

Why Is Claire Bombardier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Claire Bombardier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. (1990) (9227)
Guidelines for the process of cross-cultural adaptation of self-report measures. (2000) (8581)
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. (1993) (5221)
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. (1992) (4493)
Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder, and head) (1996) (3844)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. (2000) (3113)
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. (1995) (2640)
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) (1996) (2422)
Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group (2003) (1964)
Assessing Bias in Studies of Prognostic Factors (2013) (1901)
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. (1993) (1650)
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis (2012) (1438)
2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group (2009) (1418)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials (2013) (1418)
Evaluation of the Quality of Prognosis Studies in Systematic Reviews (2006) (1330)
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. (1991) (1278)
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. (2001) (1258)
Outcome Measures for Low Back Pain Research: A Proposal for Standardized Use (1998) (1235)
Multidisciplinary rehabilitation for chronic low back pain: systematic review (2001) (957)
The development of a comorbidity index with physical function as the outcome. (2005) (954)
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement (2004) (858)
Measuring disease-specific quality of life in clinical trials. (1986) (740)
Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations. (2000) (689)
Erratum: Development of an upper extremity outcome measure: The DASH (Disabilities of the Arm, Shoulder, and Hand) (American Journal of Industrial Medicine (1996) 29:6 (602-608)) (1996) (662)
Exercise for treating fibromyalgia syndrome. (2007) (632)
Health-Related Quality of Life after Knee Replacement: Results of the Knee Replacement Patient Outcomes Research Team Study* (1998) (591)
Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement (2006) (508)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison (2006) (484)
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (2008) (464)
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state (2004) (441)
Development of a measure of physical function for patients with bone and soft tissue sarcoma (1996) (432)
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. (1997) (423)
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. (1987) (409)
A Systematic Review of the Prognosis of Acute Whiplash and a New Conceptual Framework to Synthesize the Literature (2001) (390)
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. (2002) (381)
Health-related quality of life after knee replacement. (1998) (370)
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. (2003) (366)
Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. (1986) (346)
Recommendations for the Cross-Cultural Adaptation of the DASH & QuickDASH Outcome Measures (2007) (341)
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. (2013) (325)
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. (2008) (318)
Biomechanical and psychosocial risk factors for low back pain at work. (2001) (316)
Minimal clinically important difference. Low back pain: outcome measures. (2001) (310)
Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. (2002) (306)
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs (2012) (303)
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study (2012) (292)
Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. (1995) (292)
Back schools for non-specific low back pain. (2004) (286)
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study (2004) (286)
Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. (1995) (281)
Back Schools for Nonspecific Low Back Pain: A Systematic Review Within the Framework of the Cochrane Collaboration Back Review Group (2005) (281)
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. (1993) (280)
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onside. (1998) (270)
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. (2002) (268)
Outcome Measures for Studying Patients with Low Back Pain (1994) (263)
A taxonomy for responsiveness. (2001) (257)
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. (2001) (247)
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative (2013) (244)
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis (1990) (235)
Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. (2009) (229)
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. (2005) (217)
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status (2005) (212)
Effect sizes of non-surgical treatments of non-specific low-back pain (2007) (208)
Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. (1999) (206)
Minimal disease activity for rheumatoid arthritis: a preliminary definition. (2005) (203)
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled t (2000) (203)
Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. (1995) (187)
Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. (2006) (184)
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. (1994) (183)
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. (2000) (183)
Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. (2000) (182)
Physical therapy management of low back pain: an exploratory survey of therapist approaches. (2001) (180)
Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis (2008) (176)
Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. (1997) (175)
Serious infections in a population‐based cohort of 86,039 seniors with rheumatoid arthritis (2013) (174)
Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. (2007) (173)
"Are you better?" A qualitative study of the meaning of recovery. (2001) (173)
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. (2007) (171)
Predictors for remission in rheumatoid arthritis patients: A systematic review (2010) (169)
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis (2016) (169)
A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. (1993) (162)
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. (1999) (161)
Clinimetric and psychometric strategies for development of a health measurement scale. (1999) (154)
Variation in orthopedic surgeons' perceptions of the indications for and outcomes of knee replacement. (1995) (152)
The context of measuring disability: does it matter whether capability or performance is measured? (1996) (150)
Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. (1999) (150)
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. (1992) (148)
Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum (2005) (147)
Worker productivity outcome measures in arthritis. (2007) (146)
A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. (2007) (144)
Quality of Primary Care Guidelines for Acute Low Back Pain (2004) (141)
A methodologic framework for developing and selecting endpoints in clinical trials. (1982) (139)
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis (2010) (139)
The role of children in reporting their physical disability. (1995) (138)
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. (1990) (138)
Reliability, validity, and responsiveness of five at‐work productivity measures in patients with rheumatoid arthritis or osteoarthritis (2010) (136)
Classification systems of soft tissue disorders of the neck and upper limb: do they satisfy methodological guidelines? (1996) (135)
Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature (2012) (131)
Increased risk of mycobacterial infections associated with anti-rheumatic medications (2015) (128)
Measuring Worker Productivity: Frameworks and Measures (2009) (124)
Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety (2012) (122)
1999 Young Investigator Research Award Winner: Prognostic Factors for Time Receiving Workers’ Compensation Benefits in a Cohort of Patients With Low Back Pain (2000) (122)
A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. (1982) (121)
Measurement of functional status, quality of life, and utility in rheumatoid arthritis. (1990) (119)
Methodological considerations in functional assessment. (1987) (119)
Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies. (2008) (118)
Waiting times for knee-replacement surgery in the United States and Ontario. (1994) (117)
Accuracy of administrative data for assessing outcomes after knee replacement surgery. (1997) (117)
Reliability and Validity of the Body Image after Breast Cancer Questionnaire (2006) (117)
Accuracy of Canadian Health Administrative Databases in Identifying Patients With Rheumatoid Arthritis: A Validation Study Using the Medical Records of Rheumatologists (2013) (116)
Group Education Interventions for People With Low Back Pain: An Overview of the Literature (1994) (116)
What do we know about the reliability and validity of physical examination tests used to examine the upper extremity? (1999) (116)
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. (1994) (115)
Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. (1988) (113)
Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS‐RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA‐WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Qu (2011) (113)
A Critical Review of Reviews on the Treatment of Chronic Low Back Pain (2001) (112)
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis. (2016) (106)
An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. (2006) (106)
Prognostic factors for time receiving workers' compensation benefits in a cohort of patients with low back pain. (2000) (105)
The Epidemiology of Rheumatoid Arthritis in Ontario, Canada (2014) (104)
An evidence-based evaluation of the gastrointestinal safety of coxibs. (2002) (102)
The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events. (1993) (102)
An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance (2014) (102)
An experiment in reducing interobserver variability of the examination for joint tenderness. (1988) (101)
Physician enthusiasm as an explanation for area variation in the utilization of knee replacement surgery. (1999) (101)
Preference for endpoint measures in clinical trials: results of structured workshops. (1982) (100)
Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? (1999) (99)
The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs. (1998) (94)
The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review (2011) (94)
Testing a New Theory of Patient Satisfaction With Treatment Outcome (2004) (93)
Classification systems for upper-limb musculoskeletal disorders in workers: a review of the literature. (2003) (92)
Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis. (2010) (90)
Socioeconomic factors affecting the utilization of surgical operations. (1977) (90)
Employment-Related Factors in Chronic Pain and Chronic Pain Disability (2001) (88)
Initial patterns of clinical care and recovery from whiplash injuries: a population-based cohort study. (2005) (87)
Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. (1988) (87)
Cost‐effectiveness of biologic response modifiers compared to disease‐modifying antirheumatic drugs for rheumatoid arthritis: A systematic review (2011) (86)
NSAID induced ulcers. An emerging epidemic? (1990) (85)
A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis (2001) (84)
Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (2010) (84)
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative (2012) (81)
Quality of reporting of randomized controlled trials of herbal medicine interventions. (2006) (81)
Outcome assessments in the evaluation of treatment of spinal disorders. Introduction. (2000) (80)
Herbal Medicine for Low Back Pain: A Cochrane Review (2007) (80)
Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. (1992) (77)
Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis (2015) (76)
Use of mainstream nonpharmacologic treatment by patients with arthritis. (2004) (75)
A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group. (1991) (74)
The effectiveness of a regulatory strategy in containing hospital costs. The Ontario experience, 1967-1981. (1983) (74)
Pathologic features of diabetic thick skin. (1987) (73)
Herbal medicine for low back pain. (2006) (73)
Cochrane back review group. (2003) (71)
Minimal clinically important difference module: summary, recommendations, and research agenda. (2001) (71)
Trends in Excess Mortality Among Patients With Rheumatoid Arthritis in Ontario, Canada (2015) (71)
Spine Focus Issue Introduction : Outcome Assessments in the Evaluation of Treatment of Spinal Disorders (2000) (70)
Epidemiology of musculoskeletal disorders (complaints) and related disability in Canada. (1985) (69)
Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada. (1993) (68)
Measuring health in injured workers: a cross-sectional comparison of five generic health status instruments in workers with musculoskeletal injuries. (1996) (68)
A Guide to Interpreting Epidemiologic Studies on the Etiology of Back Pain (1994) (67)
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations (2008) (65)
Time to Treatment for New Patients with Rheumatoid Arthritis in a Major Metropolitan City (2011) (65)
Early aggressive care and delayed recovery from whiplash: isolated finding or reproducible result? (2007) (65)
Effects of occupational therapy home service on patients with rheumatoid arthritis (1991) (64)
Kidney biopsy in systemic lupus erythematosus (1994) (63)
European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus. (2003) (61)
Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. (1991) (60)
Systematic Review and Critical Appraisal of Validation Studies to Identify Rheumatic Diseases in Health Administrative Databases (2013) (60)
Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment. (2016) (60)
WITHDRAWN: Multidisciplinary bio-psycho-social rehabilitation for chronic low-back pain. (2007) (59)
Uricosuric medications for chronic gout. (2014) (59)
Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study (2015) (58)
Herbal medicine for low back pain: a Cochrane review. (2007) (58)
Quality care in seniors with new‐onset rheumatoid arthritis: A Canadian perspective (2011) (57)
Functional disability in early rheumatoid arthritis: description and risk factors. (1994) (56)
Measuring the Impact of Arthritis on Worker Productivity: Perspectives, Methodologic Issues, and Contextual Factors (2011) (56)
How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey. (1998) (56)
Controversies in COX-2 selective inhibition. (2002) (55)
The Reliability of Physical Examination for Carpal Tunnel Syndrome (1998) (53)
The Cochrane Collaboration Back Review Group for spinal disorders. (1997) (53)
The Value of Magnetic Resonance Imaging and Ultrasound in Undifferentiated Arthritis: A Systematic Review (2011) (52)
Validity of rheumatoid arthritis diagnoses listed in the Saskatchewan Hospital Separations Database. (1993) (51)
Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. (2014) (48)
Back belt use for prevention of occupational low back pain: a systematic review. (2005) (47)
Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. (1989) (47)
Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. (2002) (47)
Measuring Pain and Efficacy of Pain Treatment in Inflammatory Arthritis: A Systematic Literature Review (2012) (47)
Limited search strategies were effective in finding relevant nonrandomized studies. (2006) (46)
Folic Acid and Folinic Acid for Reducing Side Effects in Patients Receiving Methotrexate for Rheumatoid Arthritis (2014) (46)
Views on radiography use for patients with acute low back pain among chiropractors in an Ontario community. (2002) (45)
The Rising Burden of Rheumatoid Arthritis Surpasses Rheumatology Supply in Ontario (2013) (43)
An evidence-informed, integrated framework for rheumatoid arthritis care. (2008) (43)
Implementing evidence-based guidelines for radiography in acute low back pain: a pilot study in a chiropractic community. (2004) (41)
Lack of concordance between the ICD-9 classification of soft tissue disorders of the neck and upper limb and chart review diagnosis: one steel mill's experience. (1996) (40)
Describing the Burden of Upper-Extremity Musculoskeletal Disorders in Newspaper Workers: What Difference do Case Definitions Make? (2000) (40)
Time-trends in gastroprotection with NSAIDs (2010) (39)
Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort (2009) (39)
Ontario patients' acceptance of waiting times for knee replacements. (1994) (39)
The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. (2014) (38)
Reaching those most in need: A scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis (2011) (38)
Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. (2011) (38)
Methodological quality and homogeneity influenced agreement between randomized trials and nonrandomized studies of the same intervention for back pain. (2008) (38)
Advantages and limitations of utility assessment methods in rheumatoid arthritis. (2007) (37)
Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis (2010) (37)
Comprehensive Nonsurgical Treatment Versus Self-directed Care to Improve Walking Ability in Lumbar Spinal Stenosis: A Randomized Trial. (2018) (37)
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis (2016) (37)
Quality of life of patients on long-term total parenteral nutrition at home (2007) (37)
Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort (2012) (37)
Effectiveness of the primary therapist model for rheumatoid arthritis rehabilitation: a randomized controlled trial. (2006) (36)
The effectiveness of back schools in the treatment of low back pain (1999) (36)
OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research (2016) (35)
The Work Instability Scale for rheumatoid arthritis predicts arthritis‐related work transitions within 12 months (2010) (35)
Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research (2014) (35)
Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. (2002) (35)
Effectiveness and Safety of Etanercept in Patients with Psoriatic Arthritis in a Canadian Clinical Practice Setting: The REPArE Trial (2011) (35)
Response to expression of concern regarding VIGOR study. (2006) (35)
Examining Heterogeneity in Meta-Analysis: Comparing Results of Randomized Trials and Nonrandomized Studies of Interventions for Low Back Pain (2008) (34)
Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis. (1987) (34)
A summary of economic evaluations published in the field of rheumatology and related disciplines. (1997) (34)
Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data. (2016) (34)
Low Back Pain Prognosis: Structured Review of the Literature (2000) (33)
Reiter's syndrome after Campylobacter jejuni enteritis. (1980) (33)
The Work Instability Scale for Rheumatoid Arthritis (RA-WIS): Does it work in osteoarthritis? (2010) (33)
Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid Arthritis (2002) (32)
Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. (1994) (31)
Low dose cyclosporine in rheumatoid arthritis: a pilot study. (1987) (31)
Looking into the crystal ball: can we estimate the lifetime cost of rheumatoid arthritis? (1985) (31)
Diagnostic and Prognostic Value of Antibodies and Soluble Biomarkers in Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (30)
Identifying the Best Treatment Among Common Nonsurgical Neck Pain Treatments: A Decision Analysis (2008) (30)
Report of the OMERACT task force on economic evaluation. Outcome Measures in Rheumatology. (1999) (30)
Reporting Random Controlled Trials of Herbal Medicines (2006) (29)
Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system (2014) (29)
Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review. (2014) (29)
Do Chiropractors Adhere to Guidelines for Back Radiographs?: A Study of Chiropractic Teaching Clinics in Canada (2007) (29)
Criteria for assessing disease activity in systemic lupus erythematosus. (1989) (29)
Randomized controlled trials of herbal interventions underreport important details of the intervention. (2011) (28)
How should importance and severity ratings be combined for item reduction in the development of health status instruments? (1999) (28)
Herbal Medicine for Low Back Pain: A Cochrane Review. (2016) (27)
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. (2002) (27)
Meta-analysis of injectable gold in rheumatoid arthritis. (1989) (27)
Preliminary development of a responder index for chronic low back pain. (2007) (26)
The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative (2016) (26)
Sensibility of five at-work productivity measures was endorsed by patients with osteoarthritis or rheumatoid arthritis. (2013) (26)
Systematic Monitoring of Disease Activity Using an Outcome Measure Improves Outcomes in Rheumatoid Arthritis (2010) (25)
Adherence to radiography guidelines for low back pain: a survey of chiropractic schools worldwide. (2008) (24)
Auranofin Therapy and Quality of Life in I. Patients with Rheumatoid Arthritis (1986) (24)
Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: a cost-effectiveness analysis. (2006) (24)
Allopurinol for chronic gout. (2014) (24)
An empirical study using permutation-based resampling in meta-regression (2012) (24)
Quality of life in patients with rheumatoid arthritis: does abatacept make a difference? (2007) (24)
Quality indicators in rheumatoid arthritis care: using measurement to promote quality improvement (2012) (24)
Patterns of Care Among Patients Referred to Rheumatologists in Ontario, Canada (2017) (23)
PubMed had a higher sensitivity than Ovid-MEDLINE in the search for systematic reviews. (2011) (22)
Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]. (2006) (21)
Focusing on care research: a challenge and an opportunity. (2004) (20)
Injectable gold for rheumatoid arthritis. (1997) (20)
A review of cost-effectiveness analyses in rheumatology and related disciplines (1998) (20)
Safety of Pain Therapy During Pregnancy and Lactation in Patients with Inflammatory Arthritis: A Systematic Literature Review (2012) (20)
Controversies in the analysis of longterm clinical trials of slow acting drugs. (1985) (20)
Paracetamol for the Management of Pain in Inflammatory Arthritis: A Systematic Literature Review (2012) (20)
A comparison of patients' responses about their disability with and without attribution to their affected area. (2001) (19)
Trends in hospital use for mechanical neck and back problems in Ontario and the United States: discretionary care in different health care systems. (1998) (19)
Preventing attacks of acute gout when introducing urate-lowering therapy: a systematic literature review. (2014) (19)
Early Management of Newly Diagnosed Rheumatoid Arthritis by Canadian Rheumatologists: A National, Multicenter, Retrospective Cohort (2011) (19)
Five questions predicted long-term, severe, back-related functional limitations: evidence from three large prospective studies. (2011) (19)
Capturing health care utilization after occupational low-back pain: development of an interviewer-administered questionnaire. (1999) (18)
Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II. (2014) (18)
Current topics on models of care in the management of inflammatory arthritis. (2006) (18)
Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada (2016) (18)
Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment (2020) (17)
A randomized trial of a decisional aid for mental capacity assessments. (1993) (17)
Clinical utility and specificity of anticardiolipin antibodies. (1991) (17)
Improving the Quality of Reporting of Randomised Controlled Trials Evaluating Herbal Interventions: Implementing the CONSORT Statement (2008) (17)
Description of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis (2014) (16)
Utilization of Physiotherapy and Occupational Therapy by Ontario Rheumatologists in Managing Rheumatoid Arthritis: A Survey (2003) (16)
Further Qualification of a Therapeutic Responder Index for Patients with Chronic Low Back Pain (2011) (16)
Interventions for tophi in gout: a Cochrane systematic literature review. (2014) (15)
Hospitalizations for back and neck problems: a comparison between the Province of Ontario and Washington State. (1998) (15)
Canadian Variation by Province in Rheumatoid Arthritis Initiating Anti–Tumor Necrosis Factor Therapy: Results from the Optimization of Adalimumab Trial (2010) (15)
Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Best Practices Research Initiative. (2019) (15)
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI) (2018) (15)
Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage (2019) (13)
The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery (2016) (13)
Clinical trials in fibrositis: a critical review and future directions. (1989) (13)
Interventions for tophi in gout. (2014) (13)
Rheumatoid Arthritis Surveillance in Ontario: Monitoring the Burden, Quality of Care and Patient Outcomes through Linkage of Administrative Health Data. (2015) (13)
Prophylaxis for Latent Tuberculosis Infection Prior to Anti–Tumor Necrosis Factor Therapy in Low‐Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis (2013) (13)
Safety and Efficacy of On-demand Versus Continuous Use of Nonsteroidal Antiinflammatory Drugs in Patients with Inflammatory Arthritis: A Systematic Literature Review (2012) (13)
Simplified search strategies were effective in identifying clinical trials of pharmaceuticals and physical modalities. (2005) (13)
A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations. (2018) (12)
OMERACT 5 Economics Working Group: summary, recommendations, and research agenda. (2001) (12)
Emerging Issues in Pharmacological Management of Rheumatoid Arthritis: Results of a National Needs Assessment Survey Identifying Practice Variations for the Development of Canadian Rheumatology Association Clinical Practice Recommendations (2012) (12)
Strategies for Outcome Research in Spinal Disorders: An Introduction (1994) (12)
High Disease Activity Is Associated with Self-reported Depression and Predicts Persistent Depression in Early Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative (2018) (11)
Algorithm for Identification of Undifferentiated Peripheral Inflammatory Arthritis: A Multinational Collaboration Through the 3e Initiative (2011) (11)
Effect of a prototype lumbar spinal stenosis belt versus a lumbar support on walking capacity in lumbar spinal stenosis: a randomized controlled trial. (2019) (11)
Outcomes of Home-Based Rehabilitation Provided by Primary Therapists for Patients with Rheumatoid Arthritis: Pilot Study (2005) (11)
Use of grade membership analysis to profile the practice styles of individual physicians in the management of acute low back pain. (2000) (11)
Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative (2017) (11)
HLA antigens and nailfold capillary microscopy studies in patients with insulin dependent and noninsulin dependent diabetes mellitus and limited joint mobility. (1990) (10)
Setting priorities in arthritis care: Care III Conference. (2006) (10)
Diagnostic and Predictive Value of Acute-phase Reactants in Adult Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (10)
Rasch analysis informed modifications to the Work Instability Scale for Rheumatoid Arthritis for use in work-related upper limb disorders. (2011) (10)
Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews. (2014) (10)
Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI). (2018) (10)
Assessing damage in individual joints in rheumatoid arthritis: a new method based on the Larsen system. (2004) (10)
Utilization and costs of lumbar and full spine radiography by Ontario chiropractors from 1994 to 2001. (2009) (10)
A critical appraisal of toxicity indexes in rheumatology. (1995) (10)
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology. (1999) (10)
The boot camp program for lumbar spinal stenosis: a protocol for a randomized controlled trial (2016) (9)
Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis (2017) (9)
Effect of active TENS versus de-tuned TENS on walking capacity in patients with lumbar spinal stenosis: a randomized controlled trial (2019) (9)
A pattern recognition approach to the development of a classification system for upper-limb musculoskeletal disorders of workers. (2007) (9)
Influence of H. pylori and other potential risk factors on clinical gi events in a double-blind outcome study of rofecoxib VS. Naproxen (2000) (9)
Measuring disability: guidelines for rheumatology studies. (1983) (9)
Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine. (1988) (9)
How to Ascertain Drug Safety in the Context of Benefit. Controversies and Concerns (2009) (9)
Septic arthritis due to saccharomyces species in a patient with chronic rheumatoid arthritis. (1982) (8)
Stratilying the risk of clinical upper Gl events in NSAID users: Results from a double-blind outcomes study (2001) (8)
Identifying the best treatment among common nonsurgical neck pain treatments: a decision analysis. (2009) (8)
Current quality-of-life research challenges in arthritis relevant to the issue of clinical significance. (1991) (8)
Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis of the lower limbs (2003) (8)
Diagnostic and Prognostic Value of Synovial Biopsy in Adult Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (8)
The Value of Conventional Radiographs in Undifferentiated Arthritis: A Systematic Review (2011) (7)
Identifying the Best Treatment Among Common Nonsurgical Neck Pain Treatments (2008) (7)
The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario (2019) (7)
Costing: in search of a question. (1981) (7)
Letters to the Editor: In Reply: (1999) (7)
Clinical Composite Measures of Disease Activity for Diagnosis and Followup of Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (7)
Patients Considered as Having Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (7)
Fifteen Years of the Cochrane Back Review Group (2013) (6)
8 – The epidemiology of regional musculoskeletal disorders: Canada (1985) (6)
An Introduction to Therapeutic Trials for Low Back Pain (1994) (6)
Give observational studies a chance: better observational studies make better economic evaluations. (1999) (6)
Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD (2019) (5)
Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI Registries (2019) (5)
Convening Expert Panels to Identify Mental Capacity Assessment Items (1995) (5)
Rofecoxib and clinically significant gastrointestinal events. (2011) (5)
Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists (2010) (5)
Changes in Opioid Prescribing Behaviors among Family Physicians Who Participated in a Weekly Tele-Mentoring Program (2019) (4)
Methodologic issues in international rheumatologic clinical epidemiology. (1983) (4)
Gastrointestinal (GI) co-therapy, procedures, and hospitalizations in a GI outcomes study of rofecoxib vs. naproxen in rheumatoid arthritis (2000) (4)
Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial. (1992) (4)
A Pilot Study of CyA in Patients with Rheumatoid Arthritis (RA) (1985) (4)
Collection of Anti-Rheumatic Medication Data from Both Patients and Rheumatologists Shows Strong Agreement in a Real World Clinical Cohort: The Ontario Best Practices Research Initiative (OBRI) a Rheumatoid Arthritis Cohort. (2019) (4)
Diagnostic and Prognostic Value of Genetics in Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (4)
Collection of Anti-Rheumatic Medication Data from Both Patients and Rheumatologists Shows Strong Agreement in a Real World Clinical Cohort: The Ontario Best Practices Research Initiative (OBRI) a Rheumatoid Arthritis Cohort. (2019) (4)
Diagnostic and Prognostic Value of History-taking and Physical Examination in Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (4)
Health care costs of rheumatoid arthritis: A longitudinal population study (2021) (4)
SAT0196 Time to discontinuation of biologic therapy by mechanism of action in rheumatoid arthritis: results from the ontario best practice research initiative (OBRI) cohort (2018) (4)
Discontinuation of biologic therapy due to lack/loss of response and adverse events is similar between TNFi and non-TNFi class: Results from a real-world rheumatoid arthritis cohort. (2020) (4)
Allopurinol for chronic gout (Protocol) (2013) (4)
FRI0194 Identifying Patients with Rheumatoid Arthritis in Primary Care Electronic Medical Records (2014) (3)
Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario (2009) (3)
Differential influence of Clinical Disease Activity Index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative. (2021) (3)
Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis (2021) (3)
Effect of TENS Versus Placebo on Walking Capacity in Patients With Lumbar Spinal Stenosis: A Protocol for a Randomized Controlled Trial (2016) (3)
Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results (2019) (3)
Injectable gold for rheumatoid arthritis (Review) (2010) (3)
Classifying the forest or the trees (2003) (3)
ECU convention 2017 research presentations (2017) (3)
Estimating Disease Activity in Rheumatoid Arthritis (1984) (3)
FRI0518 Epidemiology of rheumatoid arthritis in a universal public health care system: results from the ontario ra administrative database (ORAD). (2013) (3)
Some pitfalls of the case-control approach to the investigation of rheumatoid disease. (1979) (3)
OP0211 TIME TO DISCONTINUATION OF TOFACITINIB AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT METHOTREXATE: DATA FROM A RHEUMATOID ARTHRITIS COHORT (2020) (2)
How to Investigate and Follow Up Undifferentiated Peripheral Inflammatory Arthritis? 3e Initiative 2008–2009: Systematic Reviews and Clinical Algorithm (2011) (2)
Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal Study (2020) (2)
Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (2022) (2)
Patient, Rheumatologist and Therapist Perspectives on the Implementation of an Allied Health Rheumatology Triage (AHRT) Initiative in Ontario Rheumatology Clinics (2020) (2)
285 COMPARISON OF MEASUREMENT PROPERTIES OF FIVE AT-WORK DISABLITY MEASURES IN PERSONS WITH OSTEOARTHRITIS (2007) (2)
Practical issues in clinical trials as applied to current state of the art in rheumatology trials. (1983) (2)
Botanical medicine for low‐back pain (2003) (2)
OMERACT Conference on outcome measures in rheumatoid arthritis clinical trials : acknowledgements (1993) (2)
SAT0049 DIFFERENCES BETWEEN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS IN TIME TO ACHIEVING CDAI BUT NOT FATIGUE LOW DISEASE ACTIVITY AND REMISSION: DATA FROM THE OBRI REGISTRY (2020) (1)
PP-4-39 Body image after breast cancer: Results from a patient derived measure (1996) (1)
Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis. (1992) (1)
THU0425 Cigarette Smoking and Disease Activity in Rheumatoid Arthritis Patients: Results from Ontario Best Practice Research Initiative (OBRI) (2014) (1)
Greater Injury Leads to More Treatment for Whiplash: No Surprises Here—Reply (2006) (1)
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs (2022) (1)
Re: Bouter L, Pennick V, Bombardier C. Cochrane back review group. Spine. 2003;28 : 1215-1218. - Response (2004) (1)
OP0337-HPR Predictors of patient reported decision to discontinue anti-rheumatic medication in rheumatoid arthritis patients: data from a rheumatoid arthritis cohort (2017) (1)
Population-Based Risk of Mycobacterial Infections Associated With Anti-Tumor Necrosis Factor (anti-TNF) Therapy in Older Patients in Ontario, Canada (2013) (1)
Web figure 1 (2013) (1)
OP0137 Less healthcare resource utilisation for perforations, ulcers and bleeds with rofecoxib vs. naproxen in the vigour (vioxx gi outcomes research) study (2001) (1)
FRI0132 High disease activity is a predictor of depression and persistent depression in early rheumatoid arthritis: results from the ontario best practices research initiative (OBRI) (2017) (1)
Uricosuric medications for chronic gout (Protocol) (2013) (1)
SAT0347 Comparisons of Reporting and Level of Agreement of Co-Morbidities Ascertained from Rheumatologists, Patients and Health Administrative Data: A Data Linkage Study Among Patients with Rheumatoid Arthritis (2015) (1)
Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes (2021) (1)
Improving the quality of reporting of RCTs evaluating herbal interventions: implementing the CONSORT statement (2010) (1)
Botanical medicine for low back pain: a systematic review (2010) (1)
FRI0562 Attrition and Participant Characteristics in A Rheumatoid Arthritis Cohort (2016) (0)
RELIABILITY AND VALIDITY OF PHYSICAL EXAMINATION TESTS USED TO EXAMINE THEUPPER EXTREMITY. AUTHORS' REPLIES (1999) (0)
SP0028 Are Guidelines Really Changing Outcomes? (2013) (0)
OP-BRHE200346 1..11 (2020) (0)
RISK-FACTORS FOR DISABILITY IN EARLY RHEUMATOID-ARTHRITIS (1992) (0)
THU0120 Is Early DMARD Use Associated with Less Joint Replacement Surgery? an Analysis of 5,199 Incident Rheumatoid Arthritis (RA) Patients (2014) (0)
Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI) (2023) (0)
FRI0071 Characterization of Patient Reported Pain Medications in Rheumatoid Arthritis Patients – Results from the Ontario Best Practices Research Initiative (OBRI) (2015) (0)
Snapshot: Blot on the landscape (2005) (0)
Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI). (2020) (0)
The Impact of Managing Arthritis in Canada (2010) (0)
Einternational panel of rheumatologists in the research and expert opinion of a broad arthritis : integrating systematic literature undifferentiated peripheral inflammatory on how to investigate and follow-up Multinational evidence-based recommendations (2010) (0)
NSAID gastropathy revisited (I: Reply I) (1990) (0)
FRI0029 DEVELOPMENT OF AN ALGORITHM FOR THE CLASSIFICATION OF CARDIOVASCULAR COMORBIDITY IN RHEUMATOID ARTHRITIS: DATA FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (2019) (0)
SAT0119 Prevalence of Cardiovascular Disease and its Associations with Disease Severity in Rheumatoid Arthritis Patients – Data from the Ontario Best Practices Research Initiative (OBRI) (2015) (0)
ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 (2006) (0)
SAT0254 Patient characteristics and disease management of rheumatoid arthritis at baseline in the vigour (vioxx gi outcomes research) study: effects of disease duration (2001) (0)
PMS13 COST EFFECTIVENESS OF BIOLOGICS FOR RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW (2008) (0)
THU0125 CARDIOVASCULAR DISEASE RISK FACTORS MAY NEGATIVELY IMPACT RHEUMATOID ARTHRITIS DISEASE OUTCOMES: FINDINGS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (2019) (0)
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada (2023) (0)
Inflammatory Arthritis: A Systematic Review Diagnostic and Prognostic Value of Genetics in Undifferentiated Peripheral (2011) (0)
370 REACHING THOSE MOST IN NEED: A SCOPING REVIEW OF INTERVENTIONS TO IMPROVE HEALTH CARE QUALITY FOR DISADVANTAGED POPULATIONS WITH OSTEOARTHRITIS (2010) (0)
FRI0410 Rheumatoid arthritis (RA) care: Geographic disparities and impact of primary care physicians on access to rheumatologists (2013) (0)
Special Interest Group Worker Productivity Outcome Measures in Arthritis (2007) (0)
AB0191 Durability of First Biologic Disease-Modifying Antirheumatic Drug Is Not Influenced by Initial/early DAS28 (2016) (0)
THU0163 A DESCRIPTIVE ANALYSIS OF LONGITUDINAL CHANGES IN RELATIVE MARKET SHARE PROPORTIONS OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR TREATMENT OF RHEUMATOID ARTHRITIS: DATA FROM THE OBRI DATABASE (2019) (0)
(939): Development and preliminary validation of a responder index for patients with chronic low back pain (2006) (0)
FRI0068 Contributions of Social Determinants of Health on Remission in Rheumatoid Arthritis Patients (2016) (0)
Boot Camp Programs for Lumbar Spinal Stenosis: A Randomized Controlled Trial Comparing Outcomes following a Comprehensive vs Self-Directed Nonsurgical Approach (2017) (0)
Co-Creating Hope with Today's Innovators (2009) (0)
SAT0704 Collection of anti-rheumatic medication data from both patients and rheumatologists shows strong agreement in a real world clinical cohort: results from the ontario best practices research initiative (OBRI) (2018) (0)
OP0020 The Influence of Drug Exposures on Joint Surgeries in Rheumatoid Arthritis Patients: Cross-Provincial Comparisons (2015) (0)
Impact of Concomitant Use of Disease Modifying Antirheumatic Drugs and Methotrexate Administration Route on Durability of Biologic Treatment : Results from the Ontario Best Practice Research Initiative ( OBRI ) Cohort (2017) (0)
THU0255 Methotrexate Parenteral Administration versus Oral Delivery: A Comparison of Treatment Survival Using Ontario Best Practice Research Initiative (OBRI) Cohort (2014) (0)
POS0539 LATE ONSET RHEUMATOID ARTHRITIS HAS A SIMILAR REMISSION RATE AS YOUNGER ONSET RHEUMATOID ARTHRITIS: RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (2022) (0)
THU0348 The Influence of Drug Exposures and Comorbidity on Survival in Patients with Rheumatoid Arthritis (2015) (0)
15 Years of the Cochrane Back Review Group (2013) (0)
The British Medical Journal (1880) (0)
Special Interest Group Preliminary Development of a Responder Index for Chronic Low Back Pain (2007) (0)
“HOW ARE YOU NOW?”: A DESCRIPTION OF THE DISCORDANCE BETWEEN PATIENTS’ AND CLINICIANS’ VIEW OF OUTCOME AFTER A FRACTURE. (2008) (0)
Concomitant use of Oral vs. Subcutaneous Methotrexate at Biologic Initiation: a Comparison of Biologic Treatment Survival in the Ontario Best Practice Research Initiative (OBRI) Cohort (2017) (0)
FRI0092 Lung Disease among Rheumatoid Arthritis Patients – Results from Ontario BIOLOGICS Research Initiative (OBRI) (2014) (0)
SAT0255 Regional variation in baseline patient characteristics and disease management of rheumatoid arthritis patients in the vigour (vioxx gi outcomes research) study (2001) (0)
VARIANCE AND DISSENT Response Classifying the forest or the trees (2003) (0)
P24– Finding guidelines to AGREE on (2010) (0)
Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study (2022) (0)
Erratum: A reliability study of SLEDAI: A disease activity index for SLE (J Rheumatol (1993) 20 (657-660)) (1993) (0)
VIGOR authors comments on responses to Juni's editorial (2017) (0)
Canadian Clinical Practice Setting : The REPArE Trial Effectiveness and Safety of Etanercept in Patients with Psoriatic Arthritis in a (2011) (0)
FRI0159 Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from An Ontario Rheumatoid Arthritis Cohort (2016) (0)
British Medical Journal (1924) (0)
FRI0122 REAL-WORLD SAFETY DATA FROM PATIENTS WITH RHEUMATIC DISEASES TREATED WITH CT-P13, AN INFLIXIMAB BIOSIMILAR: AN INTERIM ANALYSIS FROM AN OBSERVATIONAL STUDY (2019) (0)
Characterization of active joint count trajectories in juvenile idiopathic arthritis (2012) (0)
Changes in Market Share of Biologic and Targeted Synthetic DiseaseModifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database. (2020) (0)
Pharmacoeconomic evaluation of new treatments: eYcacy versus eVectiveness studies? (1999) (0)
POS0449 BIOLOGICS INITIATION IN MODERATE VS SEVERE RHEUMATOID ARTHRITIS PATIENTS: PROSPECTIVE OBSERVATIONAL STUDY FROM A CANADIAN REGISTRY (2021) (0)
Back schools for non-specific low-back pain. (2004) (0)
THU0126 FACTORS AFFECTING THE DISCREPANCY BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OVER TIME (2019) (0)
How Echos Amplify: The Power of ECHO Rheumatology for Group Practice to Manage Inflammatory Arthritis & Autoimmune Disease (2023) (0)
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts (2021) (0)
THU0126 Impact of residential area on the profile of rheumatoid arthritis patients initiating their first biologic dmard: results from the ontario best practices research initiative (OBRI) (2018) (0)
Naproxen and sulindac improved symptoms of chronic inflammatory joint disease, but naproxen inhibited renal filtration, renal flow, and renal endocrine functions (1991) (0)
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative. (2022) (0)
POS0445 PHYSICIAN AND PATIENT REPORTED EFFECTIVENESS OUTCOMES ARE SIMILAR IN TOFACITINIB AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS: DATA FROM A RHEUMATOID ARTHRITIS REGISTRY IN CANADA (2021) (0)
AB0211 DIFFERENTIAL INFLUENCE OF CDAI COMPONENTS BASED ON DISEASE STATE IN RHEUMATOID ARTHRITIS PATIENTS: REAL-WORLD RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (OBRI) (2020) (0)
Necrosis Factor Therapy : Results from the Optimization of Adalimumab Trial Tumor − Canadian Variation by Province in Rheumatoid Arthritis Initiating Anti 1 (2011) (0)
Serious Lower GI Clinical Events with Non-Selective NSAID or Coxib Usa: A Double- 6lind GI Outcomes Trial of Naproxen vs Rofecoxib (2012) (0)
Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry (2022) (0)
SAT0073 Acpa and rf as predictors of sustained clinical remission in rheumatoid arthritis patients: results from the ontario best practices research initiative (OBRI) (2018) (0)
Lumbar supports and education did not reduce the incidence of low back pain in industry (1999) (0)
Critical appraisal of economic evaluations published in the field of rheumatology and related disciplines (1996) (0)
The complexity of rheumatology: Patient characteristics presented during a telemedicine education program, ECHO rheumatology (2022) (0)
FRI0045 DISEASE ACTIVITY TRAJECTORIES FOR EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS: DATA FROM THE OBRI REGISTRY (2020) (0)
Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort (2022) (0)
OP0179 DISCONTINUATION RATE OF TOFACITINIB IS SIMILAR WHEN COMPARED TO TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA (2021) (0)
Web figure 2 (2013) (0)
THU0545 THE ASSOCIATION OF RHEUMATOID ARTHRITIS WITH HEALTH CARE COSTS FROM THE PAYERS PERSPECTIVE FROM 2001-2015 (2020) (0)
Interventions for tophi in gout. (2021) (0)
THE COST-EFFECTIVENESS O F MISOPROSTOL FOR NONSTEROIDAL ANTIINFLAMMATORY GASTROINTESTINAL EVENTS DRUG-ASSOCIATED ADVERSE (2005) (0)
POR_A_213966 1..12 (2020) (0)
Alternating Electric Fields and Carcinogenesis: A New Paradigm to Avoid Missing the Elephant in the Room (2015) (0)
Rheumatoid Arthritis : OBRI Cohort Results Methotrexate Administration Route on Biologic Treatment Durability in Effect of Concomitant Disease-modifying Antirheumatic Drugs and (2019) (0)
Response to the letter to the editor by Sabour et al. (2019) Re: "Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: Methodological issues to avoid misinterpretation". (2020) (0)
FRI0163 TIME TO DISCONTINUATION OF TOFACITINAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AND WITHOUT METHOTREXATE: RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (OBRI) COHORT (2019) (0)
POS0448 DISCONTINUATION RATE OF TOFACITINIB AS MONOTHERAPY IS SIMILAR COMPARED TO COMBINATION THERAPY WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA (2021) (0)
Improving Walking Ability in Degenerative Lumbar Spinal Stenosis: A Randomized Trial Comparing 2 Self-Management Training Programs (2017) (0)
AB0206 Treatment Patterns in Rheumatoid Arthritis after Methotrexate: Data from The Ontario Best Practice Research Initiatives Cohort (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Claire Bombardier?

Claire Bombardier is affiliated with the following schools:

University of Toronto